Description

KETOSIGN MX EYE DROP is an advanced ophthalmic formulation designed to address inflammation and bacterial infections in the eyes. It contains two key active ingredients: Ketorolac Tromethamine, a non-steroidal anti-inflammatory drug (NSAID), and Moxifloxacin, a fourth-generation fluoroquinolone antibiotic. This dual-action combination ensures superior therapeutic outcomes in managing a wide range of post-surgical and infectious conditions affecting the eye.

Therapeutic Indications:

• Post-operative inflammation and pain relief

• Bacterial conjunctivitis

• Corneal ulcers and keratitis

• Inflammatory conditions due to surgery or trauma

• Prophylactic use in ophthalmic procedures

Mechanism of Action:

• Ketorolac Tromethamine reduces inflammation, redness, and pain by inhibiting prostaglandin synthesis through cyclooxygenase (COX) enzyme blockade.

• Moxifloxacin offers broad-spectrum antibacterial coverage by interfering with bacterial DNA replication, effectively targeting both Gram-positive and Gram-negative bacteria.

This combination therapy is ideal for post-operative care and acute infections, minimizing the need for multiple medications and improving patient compliance. It is also well-tolerated, with minimal ocular irritation or systemic absorption.

Key Features of KETOSIGN MX EYE DROP:

• Dual-action formula for infection control and inflammation relief

• Rapid onset of action with lasting effect

• Sterile, stable, and ophthalmologist-approved formulation

• Reduces the need for corticosteroids in post-operative care

• Safe for short-term and prophylactic ophthalmic use

• Convenient packaging with a precision dropper for accurate application

Manufacturing & Global Export by Bluepill Express

KETOSIGN MX EYE DROP is produced under strict WHO-GMP and ISO-certified conditions by Bluepill Express, a renowned pharmaceutical company in India. As a leading third-party manufacturer and global exporter, Bluepill Express delivers high-quality ophthalmic products to over 50+ countries, including regions across Asia, Africa, CIS, Europe, and Latin America.

With a commitment to innovation, compliance, and affordability, Bluepill Express supports private labeling, bulk supply, and customized export solutions for institutional buyers, hospitals, and government tenders.

Each batch of KETOSIGN MX EYE DROP undergoes rigorous quality testing to meet international regulatory standards for sterility, purity, and efficacy.

Partnering with Bluepill Express means accessing a wide portfolio of ophthalmic and ENT formulations that adhere to the latest global health standards, ensuring safety, reliability, and therapeutic value.